InsiderTradesSIGMA

InsidersTradesSigma

← Executives ★ Sign in to follow

DJ

Dylan Jackson

CEO

Cumul. flow

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Explore the full record of transactions filed by Dylan Jackson. Director active across 1 company, notably GSK plc. Cumulatively, 34 filings have been logged. History available since 9 August 2023. The latest transaction was filed on 11 July 2025 (Purchase). Regulator: RNS (LSE). All data is accessible without signup.

Companies and markets linked to Dylan Jackson

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations34 total

●

PCA of Sally Jackson ( SVP, Global Communications and CEO Office)Executives9 Oct 2025GSK plc

0London Stock Exchange (XLON)GB00BN7SWP63RNS:5859068-17

●

PCA of Sally Jackson ( SVP, Global Communications and CEO Office)Executives11 Jul 2025GSK plc

0London Stock Exchange (XLON)GB00BN7SWP63RNS:5739159-8

●

PCA of Ms S Jackson (SVP, Global Communications and CEO Office)Executives11 Jul 2025GSK plc

1 shares@ £14.490.0% of flowLondon Stock Exchange (XLON)GB00BN7SWP63RNS:5739159-1

●

PCA of Sally Jackson (SVP, Global Communications & CEO Office)Executives19 Jun 2025GSK plc

£19,88022RNS ↗

1,385 shares@ £14.35373.2% of flowLondon Stock Exchange ( XLON)GB00BN7SWP63RNS:5709676-4

●

PCA of Sally Jackson (SVP, Global Communications & CEO Office)Executives19 Jun 2025GSK plc

£20,02222RNS ↗

1,395 shares@ £14.35243.2% of flowLondon Stock Exchange ( XLON)GB00BN7SWP63RNS:5709676-3

●

PCA of Sally Jackson ( SVP, Global Communications and CEO Office)Executives10 Apr 2025GSK plc

0London Stock Exchange (XLON)GB00BN7SWP63RNS:5617047-12

●

PCA of Ms S Jackson (SVP, Global Communications and CEO Office)Executives10 Apr 2025GSK plc

1 shares@ £13.070.0% of flowLondon Stock Exchange (XLON)GB00BN7SWP63RNS:5615070-19

●

PCA of Sally Jackson ( SVP, Global Communications and CEO Office)Executives9 Jan 2025GSK plc

0London Stock Exchange (XLON)GB00BN7SWP63RNS:5498728-4

●

PCA of Ms S Jackson (SVP, Global Communications and CEO Office)Executives9 Jan 2025GSK plc

1 shares@ £13.560.0% of flowLondon Stock Exchange (XLON)GB00BN7SWP63RNS:5498728-13

●

PCA of Sally Jackson ( SVP, Global Communications and CEO Office)Executives15 Oct 2024GSK plc

0London Stock Exchange (XLON)GB00BN7SWP63RNS:5393638-18

●

PCA of Ms S Jackson (SVP, Global Communications and CEO Office)Executives10 Oct 2024GSK plc

1 shares@ £15.360.0% of flowLondon Stock Exchange (XLON)GB00BN7SWP63RNS:5386817-11

●

PCA of Sally Jackson ( SVP, Global Communications and CEO Office)Executives16 Jul 2024GSK plc

0London Stock Exchange (XLON)GB00BN7SWP63RNS:5272433-4

●

PCA of Ms S Jackson (SVP, Global Communications and CEO Office)Executives11 Jul 2024GSK plc

1 shares@ £15.080.0% of flowLondon Stock Exchange (XLON)GB00BN7SWP63RNS:5266837-17

●

PCA of Sally Jackson (SVP, Global Communications & CEO Office)Executives16 May 2024GSK plc

£20,01422RNS ↗

1,120 shares@ £17.873.4% of flowLondon Stock Exchange ( XLON)GB00BN7SWP63RNS:5190094-2

●

PCA of Sally Jackson (SVP, Global Communications & CEO Office)Executives16 May 2024GSK plc

£19,87622RNS ↗

1,112 shares@ £17.8743.4% of flowLondon Stock Exchange ( XLON)GB00BN7SWP63RNS:5190094-3

●

PCA of Sally Jackson ( SVP, Global Communications and CEO Office)Executives16 Apr 2024GSK plc

0London Stock Exchange (XLON)GB00BN7SWP63RNS:5149697-4

●

PCA of Ms S Jackson (SVP, Global Communications and CEO Office)Executives11 Apr 2024GSK plc

£39122RNS ↗

24 shares@ £16.28920.1% of flowLondon Stock Exchange (XLON)GB00BN7SWP63RNS:5143847-19

●

PCA of Sally Jackson (SVP, Global Communications & CEO Office)Executives11 Mar 2024GSK plc

£227,21226RNS ↗

13,616 shares@ £16.687141.6% of flowLondon Stock Exchange ( XLON)GB0009252882RNS:5103683-2

●

PCA of Sally Jackson (SVP, Global Communications & CEO Office)Executives12 Mar 2024GSK plc

£41,38523RNS ↗

2,476 shares@ £16.71457.6% of flowLondon Stock Exchange ( XLON)GB0009252882RNS:5103683-3

●

PCA of Ms S Jackson (SVP, Global Communications and CEO Office)Executives9 Feb 2024GSK plc

7,642 shares0N/AGB00BN7SWP63RNS:5066290-7

●

PCA of Ms S Jackson (SVP, Global Communications and CEO Office)Executives9 Feb 2024GSK plc

£59,6470RNS ↗

3,592 shares@ £16.605510.9% of flowLondon Stock Exchange (XLON)GB00BN7SWP63RNS:5066290-8

●

PCA of Ms S Jackson (SVP, Global Communications and CEO Office)Executives9 Feb 2024GSK plc

£59,64723RNS ↗

3,592 shares@ £16.605510.9% of flowLondon Stock Exchange (XLON)GB00BN7SWP63RNS:5066262-8

●

PCA of Ms S Jackson (SVP, Global Communications and CEO Office)Executives9 Feb 2024GSK plc

7,642 shares0N/AGB00BN7SWP63RNS:5066262-7

●

PCA of Sally Jackson ( SVP, Global Communications and CEO Office)Executives16 Jan 2024GSK plc

0London Stock Exchange (XLON)GB00BN7SWP63RNS:5039401-4

●

PCA of Ms S Jackson (SVP, Global Communications and CEO Office)Executives11 Jan 2024GSK plc

£33022RNS ↗

21 shares@ £15.7210.1% of flowLondon Stock Exchange (XLON)GB00BN7SWP63RNS:5034561-19

25 of 34 declarations

About Dylan Jackson

Dylan Jackson has 32 filings in total. In the recent filings sampled here, purchases amount to EUR 48,248 and sales to EUR 269,821, covering the period from 2023-08-10 to 2025-10-13. They are PCA of Sally Jackson ( SVP, Global Communications and CEO Office) at GSK plc.